Cargando…
Cocaethylene: When Cocaine and Alcohol Are Taken Together
Cocaine is taken frequently together with ethanol and this combination produces a psychoactive metabolite called cocaethylene which has similar properties to the parent drug and may be more cardiotoxic. Cocaethylene has a longer half-life than cocaine, so that people who combine cocaine and ethanol...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956485/ https://www.ncbi.nlm.nih.gov/pubmed/35345678 http://dx.doi.org/10.7759/cureus.22498 |
_version_ | 1784676576889143296 |
---|---|
author | Pergolizzi, Joseph Breve, Frank Magnusson, Peter LeQuang, Jo Ann K Varrassi, Giustino |
author_facet | Pergolizzi, Joseph Breve, Frank Magnusson, Peter LeQuang, Jo Ann K Varrassi, Giustino |
author_sort | Pergolizzi, Joseph |
collection | PubMed |
description | Cocaine is taken frequently together with ethanol and this combination produces a psychoactive metabolite called cocaethylene which has similar properties to the parent drug and may be more cardiotoxic. Cocaethylene has a longer half-life than cocaine, so that people who combine cocaine and ethanol may experience a longer-lasting, as well as more intense, psychoactive effect. Cocaethylene is the only known instance where a new psychoactive substance is formed entirely within the body. Although known to science for decades, cocaethylene has not been extensively studied and even its metabolic pathways are not entirely elucidated. Like its parent drug, cocaethylene blocks the reuptake of dopamine and increases post-synaptic neuronal activity; the parent drug may also block reuptake of serotonin as well. Cocaethylene has been studied in animal models in terms of its pharmacology and its potential neurological effects. Since the combination of cocaine and alcohol is commonly used, it is important for clinicians to be aware of cocaethylene, its role in prolonging or intensifying cocaine intoxication, and how it may exacerbate cocaine-induced cardiovascular disorders. Most cardiac-related risk assessment tools do not ask about cocaine use, which can prevent clinicians from making optimal therapeutic choices. Greater awareness of cocaethylene is needed for clinicians, and those who use cocaine should also be aware of the potential for polysubstance use of cocaine and ethanol to produce a potentially potent and long-lasting psychoactive metabolite. |
format | Online Article Text |
id | pubmed-8956485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-89564852022-03-27 Cocaethylene: When Cocaine and Alcohol Are Taken Together Pergolizzi, Joseph Breve, Frank Magnusson, Peter LeQuang, Jo Ann K Varrassi, Giustino Cureus Cardiology Cocaine is taken frequently together with ethanol and this combination produces a psychoactive metabolite called cocaethylene which has similar properties to the parent drug and may be more cardiotoxic. Cocaethylene has a longer half-life than cocaine, so that people who combine cocaine and ethanol may experience a longer-lasting, as well as more intense, psychoactive effect. Cocaethylene is the only known instance where a new psychoactive substance is formed entirely within the body. Although known to science for decades, cocaethylene has not been extensively studied and even its metabolic pathways are not entirely elucidated. Like its parent drug, cocaethylene blocks the reuptake of dopamine and increases post-synaptic neuronal activity; the parent drug may also block reuptake of serotonin as well. Cocaethylene has been studied in animal models in terms of its pharmacology and its potential neurological effects. Since the combination of cocaine and alcohol is commonly used, it is important for clinicians to be aware of cocaethylene, its role in prolonging or intensifying cocaine intoxication, and how it may exacerbate cocaine-induced cardiovascular disorders. Most cardiac-related risk assessment tools do not ask about cocaine use, which can prevent clinicians from making optimal therapeutic choices. Greater awareness of cocaethylene is needed for clinicians, and those who use cocaine should also be aware of the potential for polysubstance use of cocaine and ethanol to produce a potentially potent and long-lasting psychoactive metabolite. Cureus 2022-02-22 /pmc/articles/PMC8956485/ /pubmed/35345678 http://dx.doi.org/10.7759/cureus.22498 Text en Copyright © 2022, Pergolizzi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Pergolizzi, Joseph Breve, Frank Magnusson, Peter LeQuang, Jo Ann K Varrassi, Giustino Cocaethylene: When Cocaine and Alcohol Are Taken Together |
title | Cocaethylene: When Cocaine and Alcohol Are Taken Together |
title_full | Cocaethylene: When Cocaine and Alcohol Are Taken Together |
title_fullStr | Cocaethylene: When Cocaine and Alcohol Are Taken Together |
title_full_unstemmed | Cocaethylene: When Cocaine and Alcohol Are Taken Together |
title_short | Cocaethylene: When Cocaine and Alcohol Are Taken Together |
title_sort | cocaethylene: when cocaine and alcohol are taken together |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956485/ https://www.ncbi.nlm.nih.gov/pubmed/35345678 http://dx.doi.org/10.7759/cureus.22498 |
work_keys_str_mv | AT pergolizzijoseph cocaethylenewhencocaineandalcoholaretakentogether AT brevefrank cocaethylenewhencocaineandalcoholaretakentogether AT magnussonpeter cocaethylenewhencocaineandalcoholaretakentogether AT lequangjoannk cocaethylenewhencocaineandalcoholaretakentogether AT varrassigiustino cocaethylenewhencocaineandalcoholaretakentogether |